<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.2 20190208//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="preprint">
<?all-math-mml yes?>
<?use-mml?>
<?origin ukpmcpa?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">bioRxiv</journal-id>
<journal-title-group>
<journal-title>bioRxiv : the preprint server for biology</journal-title>
</journal-title-group>
<issn pub-type="ppub"/>
</journal-meta>
<article-meta>
<article-id pub-id-type="manuscript">EMS104093</article-id>
<article-id pub-id-type="doi">10.1101/2020.11.11.377713</article-id>
<article-id pub-id-type="archive">PPR237056</article-id>
<article-version article-version-type="publisher-id">2</article-version>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>
<italic>In silico</italic> analyses on the comparative sensing of SARS-CoV-2 mRNA by intracellular TLRs of human</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Choudhury</surname>
<given-names>Abhigyan</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="fn" rid="FN1">#</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Das</surname>
<given-names>Nabarun Chandra</given-names>
</name>
<xref ref-type="fn" rid="FN1">#</xref>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Patra</surname>
<given-names>Ritwik</given-names>
</name>
<xref ref-type="fn" rid="FN1">#</xref>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Mukherjee</surname>
<given-names>Suprabhat</given-names>
</name>
<uri content-type="orcid" xlink:href="http://orcid.org/0000-0002-5709-9190">http://orcid.org/0000-0002-5709-9190</uri>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="corresp" rid="CR1">*</xref>
</contrib>
</contrib-group>
<aff id="A1">
<label>1</label>Integrative Biochemistry &amp; Immunology Laboratory, Department of Animal Science, Kazi Nazrul University, Asansol-713 340, West Bengal, India</aff>
<author-notes>
<corresp id="CR1">
<label>*</label>Correspondence. Dr. Suprabhat Mukherjee, Department of Animal Science, Kazi Nazrul University, Asansol- 713 340, India E. mail: <email>babaimbc@gmail.com</email>; <email>suprabhat.mukherjee@knu.ac.in</email>
</corresp>
<fn id="FN1">
<label>#</label>
<p id="P1">Joint First Authors</p>
</fn>
</author-notes>
<pub-date pub-type="nihms-submitted">
<day>13</day>
<month>11</month>
<year>2020</year>
</pub-date>
<pub-date pub-type="preprint">
<day>11</day>
<month>11</month>
<year>2020</year>
</pub-date>
<permissions>
<license license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nd/4.0/">
<license-p>This work is licensed under a <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-nd/4.0/">CC BY-ND 4.0 International license</ext-link>.</license-p>
</license>
</permissions>
<abstract>
<p id="P2">The worldwide outbreak of COVID-19 pandemic caused by SARS-CoV-2 leads to loss of mankind and global economic stability. The continuous spreading of the disease and its pathogenesis takes millions of lives of peoples and the unavailability of appropriate therapeutic strategy makes it much more severe. Toll-like receptors (TLRs) are the crucial mediators and regulators of host immunity. The role of several TLRs in immunomodulation of host by SARSCoV-2 is recently demonstrated. However, the functionality of human intracellular TLRs including TLR3,7,8 and 9 is still being untested for sensing of viral RNA. This study is hoped to rationalize the comparative binding and sensing of SARS-CoV-2 mRNA towards the intracellular TLRs, considering the solvent-based force-fields operational in the cytosolic aqueous microenvironment that predominantly drive these reactions. Our <italic>in-silico</italic> study on the binding of all mRNAs with the intracellular TLRs shown that the mRNA of NSP10, S2, and E proteins of SARS-CoV-2 are potent enough to bind with TLR3, TLR9, and TLR7 and trigger downstream cascade reactions, and may be used as an option for validation of therapeutic option and immunomodulation against COVID-19.</p>
</abstract>
<kwd-group>
<kwd>COVID-19</kwd>
<kwd>SARS-CoV-2</kwd>
<kwd>TLRs</kwd>
<kwd>Molecular Docking</kwd>
<kwd>Molecular Dynamics (MD) Simulation</kwd>
<kwd>NSP10 mRNA</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec id="S1" sec-type="intro">
<label>1</label>
<title>Introduction</title>
<p id="P3">The worldwide outbreak of Coronavirus disease or COVID-19 pandemic caused by the Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2), leads to the infection of about 0.33% of the total world’s population causing the death of 1.24 million people by the first week of November 2020.<sup>
<xref ref-type="bibr" rid="R1">1</xref>
</sup> The continuous expansion of contagion and pathogenesis, it is taking the shape of another dark age in the history of mankind, not only to health crises but also in bankrupting the global socio-economic status. The SARS-CoV-2 belongs to the β-Coronavirus genus of a 2B group of the Coronaviridae family and is considered the third most virulent type, leading to the highest fatality rate in humans followed by the SARS-CoV and MERS-CoV.<sup>
<xref ref-type="bibr" rid="R2">2</xref>
</sup> It transmits from person to person mainly via close physical contact and by respiratory aerosols that produces during coughing, sneezing, and even talking within proximity, although some recent studies indicate transmission through fecal matters and fomite-borne contaminations.<sup>
<xref ref-type="bibr" rid="R3">3</xref>–<xref ref-type="bibr" rid="R5">5</xref>
</sup>
</p>
<p id="P4">The proteome of the virus consists of structural proteins, existing in three forms – the Spike ‘S’ protein, the Envelope ‘E’ protein and the Membrane ‘M’ protein. Along with these, 16 forms of non-structural proteins (NSPs) combining together to generate different catalytic models.<sup>
<xref ref-type="bibr" rid="R6">6</xref>
</sup> The genome, however, is much simpler and comprises of a 29,903 base long, positive-sense single-stranded RNA molecule. This (+)ssRNA genome makes it further feasible to be detectible by the intracellular Toll-like receptors (TLRs) which have a high affinity towards nucleic acid-related pathogen-associated molecular patterns (PAMPs).<sup>
<xref ref-type="bibr" rid="R7">7</xref>
</sup> Several empirical studies have presented various propositions relating the intracellular TLR 3, 7, 8, and 9 to the cytokine storm produced by the virus that majorly owes it the lethality.<sup>
<xref ref-type="bibr" rid="R8">8</xref>
</sup> Cytokine storm is apparently the incessant extreme activation of cytokine production leading to prolonged and consistent inflammatory response, which becomes almost continuous due to positive feedback loops in the TLR signaling pathways. The studies are quite successful in relating the role of TLRs in recognizing oligonucleotide PAMPs and triggering the cytokine storm.<sup>
<xref ref-type="bibr" rid="R9">9</xref>
</sup>
</p>
<p id="P5">The binding of Spike protein with the human ACE2 receptor triggers the pathogenesis of the SARS-CoV-2, leading to the activation of TLRs to activate the proliferation and production of pro-inflammatory cytokines causing cytokine storm, those results in inflammations.<sup>
<xref ref-type="bibr" rid="R10">10</xref>,<xref ref-type="bibr" rid="R11">11</xref>
</sup> From previous studies, it has been found that the spike protein shows binding efficiency with the extracellular domains of TLRs including TLR1, TLR4 and, TLR6, with the strongest affinity with TLR4.<sup>
<xref ref-type="bibr" rid="R12">12</xref>
</sup> Furthermore, the development of several <italic>in-silico</italic> multi-epitope-based peptide vaccine candidates against the SARS-CoV-2 has shown to be effectively binding with TLR3, TLR4 and, TLR5 to regulate the TLR signaling pathways activation and proliferation.<sup>
<xref ref-type="bibr" rid="R13">13</xref>
</sup> It has been found that targeting human TLRs, in an order to either block the binding of SARS-CoV-2 or by inhibiting the TLR activation and proliferation that induce the production of pro-inflammatory cytokines using certain TLR agonists, might be used as an effective therapeutic strategy against coronavirus disease.<sup>
<xref ref-type="bibr" rid="R11">11</xref>
</sup> Additionally, the continuous replication and generation of new virus within the host system indicates that there must be binding efficiency and potency with the intracellular TLRs including TLR3, 7, 8, and 9 in order to induce the severity and pathogenesis of the virus and further introduction to the new host. TLR3 is well known for its sensing capabilities of viral PAMPs and exists as a monomer that is attached to the membrane of endosomes, thereby it detects and binds to certain motifs in the invading viral RNA.<sup>
<xref ref-type="bibr" rid="R14">14</xref>
</sup> TLR7 expressed majorly in the cerebral cortex, lung, bronchus, breast, kidney, rectum, and smooth muscle tissues, and functions by adhering to the endosome and thereby binding to the viral RNAs with high guanosine and uridine content <sup>
<xref ref-type="bibr" rid="R15">15</xref>
</sup> to initiates a MyD88 signal transduction resulting in activation of NF-κB, mitogen-activated protein kinase (MAPK) cascades, as well as IRF-7 and IRF-5 activation via IL-1 receptor-associated kinases (IRAK)-1/2/4 and TNF receptor-associated factor-3/6.<sup>
<xref ref-type="bibr" rid="R16">16</xref>
</sup> The signaling finally induces the production of pro-inflammatory cytokines including IL-1β, IL-6, IL-12, TNF-α, and IFN-α.<sup>
<xref ref-type="bibr" rid="R17">17</xref>
</sup> TLR8 is expressed predominantly in the lung and the peripheral blood leucocytes and plays a major role in recognizing GU-rich viral ssRNAs including those of SARS-CoV-2.<sup>
<xref ref-type="bibr" rid="R18">18</xref>
</sup> TLR9 is predominantly expressed in the spleen, lymph node, bone marrow, and peripheral blood leukocytes and it recognizes CpG motifs in viral DNAs. However, several studies suggest its role in sensing ssRNA fragments generated by the SARS-CoV-2 genome.<sup>
<xref ref-type="bibr" rid="R19">19</xref>
</sup>
</p>
<p id="P6">However, a lack of precise knowledge regarding the nature of oligonucleotides and their ligating affinity towards the TLRs still pertains to exist. This in context is abstaining the medical research community from developing certain therapeutic interventions that would have been vitally important in this hour of severity. Our study is hoped to rationalize the picture and provide clues regarding the interaction range of the oligonucleotides towards the intracellular TLRs, considering the solvent-based force-fields operational in the cytosolic aqueous microenvironment that predominantly drive these reactions.</p>
</sec>
<sec id="S2" sec-type="materials | methods">
<label>1</label>
<title>Materials and Methods</title>
<sec id="S3">
<label>2.1</label>
<title>Data mining</title>
<p id="P7">Current literatures suggest the predominant expression of ten proteins of SARS-CoV-2.<sup>
<xref ref-type="bibr" rid="R20">20</xref>
</sup> Four of them are structural proteins – the spike protein subunits S1 and S2, the envelope protein (E), and the membrane protein (M). While the other six are non-structural proteins viz. NSP7, NSP8, NSP9, NSP10, papain-like protease (PLpro), and main protease (Mpro). So, first of all, full-length RNA sequences of the aforementioned proteins were retrieved by extensive literature research. Further, the respective sequences were subjected to pairwise alignment with the complete genome of the virus (Accession No. MT438755) available at the GenBank database of NCBI showing ~100% identity matches and 0 gap penalties. From this, it was evident that the quality of the sequences obtained was very high and equivalent to the raw original. Thereafter, crystal structures of TLR3 (PDB ID: 1ZIW) and TLR8 (PDB ID: 5WYX) were obtained from the RCSB PDB database. However, the structures of TLR7 and TLR9 were obtained by performing homology modelling in the SWISS-MODEL server from ExPASy (<ext-link ext-link-type="uri" xlink:href="https://swissmodel.expasy.org/">https://swissmodel.expasy.org/</ext-link>) by using protein sequences obtained from GenBank with Accession No. AAZ99026 and AAZ95518.1 respectively. All the crystal surface structures of TLRs and the whole genome of SARS-CoV-2 were then prepared to visualize (<xref ref-type="fig" rid="F1">Figure 1</xref>).</p>
<p id="P8">To perform further studies, PyMOL is used for removing water molecules, aboriginal heteroatoms as well as any xenobiotic ligands whenever present, and adding polar hydrogens and Kollman charges to the structures.</p>
</sec>
<sec id="S4">
<label>2.2</label>
<title>Prediction of mRNA-Protein interactions</title>
<p id="P9">The retrieved RNA sequences were subjected to the imRNA tool developed by IIIT-Delhi (<ext-link ext-link-type="uri" xlink:href="https://webs.iiitd.edu.in/raghava/imrna/">https://webs.iiitd.edu.in/raghava/imrna/</ext-link>). This tool is based on Motif—EmeRging and with Classes—Identification (MERCI) program and scans through the RNA sequences for motifs that are potent to have immunomodulatory properties.<sup>
<xref ref-type="bibr" rid="R21">21</xref>
</sup> Again, conventional high-throughput experiments for analyzing RNA-protein interactions demand heavier resources and are highly expensive, where RPISeq tool from Iowa State University (<ext-link ext-link-type="uri" xlink:href="http://pridb.gdcb.iastate.edu/RPISeq/">http://pridb.gdcb.iastate.edu/RPISeq/</ext-link>) presents a very inexpensive method of predicting RNA-protein interactions, simply by analyzing the RNA and protein sequence data.<sup>
<xref ref-type="bibr" rid="R22">22</xref>
</sup> RPISeq tool operates on machine learning algorithms and generates outputs in two major forms of RNA-protein interaction prediction parameters – the Random Forest (RF) classifier and Support Vector Machine (SVM) classifier.<sup>
<xref ref-type="bibr" rid="R23">23</xref>
</sup> Now the protein sequences of TLR3 and TLR8 were extracted from their original PDBs in FASTA format and were used along with the other sequences for the analysis with this tool.</p>
</sec>
<sec id="S5">
<label>2.3</label>
<title>Molecular docking studies and interactions visualization</title>
<p id="P10">The HDOCK server (<ext-link ext-link-type="uri" xlink:href="http://hdock.phys.hust.edu.cn/">http://hdock.phys.hust.edu.cn/</ext-link>) presents a novel algorithm which is a hybrid of template-dependent along with template-independent <italic>ab initio</italic> free docking. Moreover, it is one of the advance programme which support protein docking against DNA/RNA molecules.<sup>
<xref ref-type="bibr" rid="R24">24</xref>
</sup> Oligonucleotides have great sizes and demand heavier computing resources for the rendering of molecular models, which is seldomly feasible for any supercomputing server to provide. Thus, HDOCK was a program of choice. The retrieved PDB structures along with the RNA sequences were used for the purpose, however, the species-sensitive and intricate nature of the molecules of interest drove us to go with the template-free docking method. Thereafter, the docked complexes were further visualized with the Protein-Ligand Interaction Profiler (PLIP) tool (<ext-link ext-link-type="uri" xlink:href="https://projects.biotec.tu-dresden.de/plip-web/plip/">https://projects.biotec.tu-dresden.de/plip-web/plip/</ext-link>) it is a Python-based open-source program that provides a complete analysis and visualization of the non-covalent protein-ligand interactions even on single-atom level that include seven prime interaction types <italic>viz</italic>. hydrogen bonds, hydrophobic contacts, π-stacking, π-cation interactions, salt bridges, water bridges, and halogen bonds.<sup>
<xref ref-type="bibr" rid="R25">25</xref>
</sup>
</p>
</sec>
<sec id="S6">
<label>2.4</label>
<title>Simulation studies of the docked complexes</title>
<sec id="S7">
<label>2.4.1</label>
<title>Normal mode analysis (NMA) study</title>
<p id="P11">The so retrieved docked structures were then fed into the iMOD webserver from ChaconLab (<ext-link ext-link-type="uri" xlink:href="http://imods.chaconlab.org">http://imods.chaconlab.org</ext-link>). This program has a user-friendly GUI and is a well-recognized tool for performing normal mode analysis (NMA) and simulating various modal trajectories of protein dynamics. NMA in dihedral coordinates naturally mimics the combined functional motions of protein molecules modelled as a set of atoms connected by harmonic springs.<sup>
<xref ref-type="bibr" rid="R26">26</xref>
</sup> As output the server delivers affine modelled arrow, vector field and a modal animation to signifies the motions. Moreover, study also provide more detail profile about mobility using B-factor and deformability plots whereas eigenvalue helps to measure the relative modal stiffness of the structure.<sup>
<xref ref-type="bibr" rid="R27">27</xref>
</sup> Besides, covariance matrix implies the variations among the different mode of motions.</p>
</sec>
<sec id="S8">
<label>2.4.2</label>
<title>Molecular dynamics (MD) simulation study</title>
<p id="P12">In-silico molecular docking between receptor and ligand is not sufficient to conclude the nature of the complex, further analysis viz. MD simulation is desired to validate the structural stability of that complex. GROningen MAchine for Chemical Simulations (GROMACS) is the utmost platform for the MD simulations as it possesses ability to employ different force fields to generate simulation data not only of proteins complexes but also complexes of DNA-protein and RNA-protein.<sup>
<xref ref-type="bibr" rid="R28">28</xref>
</sup>
</p>
<p id="P13">In this work, Chemistry at Harvard Macromolecular Mechanics (CHARMM) force field was accessed initially to generate necessary input files for MD simulation.<sup>
<xref ref-type="bibr" rid="R29">29</xref>–<xref ref-type="bibr" rid="R31">31</xref>
</sup> Solution builder approach under CHARMM-GUI web tool was first add water box (TIP3 216) and then neutralizing atoms to solvate the system. In order to remove bad contacts and generate more specific outcomes periodic boundary conditions (PBC) were analysed and minimization steps were performed sequentially. Server provided outcomes were then applied on GROMACS v. 2020.1 to achieve the equilibrium (NVT- constant volume and temperature) of the system. Finally, module gmx_mdrun was accessed to run the MD simulation of the system and xmgrace was used to visualize the output of simulation as root mean square deviation (RMSD) plot, radius of gyration (Rg) plot, solvent accessible surface area (SASA) plot and hydrogen bond plot.</p>
</sec>
</sec>
<sec id="S9">
<label>2.5</label>
<title>Analysis of conformational changes of TLRs during and after MD simulation</title>
<p id="P14">Protein with conformational changes from its native form suggests it is in bounded state with any ligand.<sup>
<xref ref-type="bibr" rid="R32">32</xref>
</sup> Thus, to analyse the changes in TLRs, firstly we extract the PDBs from trajectories and then visualized using PyMOL.</p>
</sec>
</sec>
<sec id="S10" sec-type="results">
<label>3</label>
<title>Results</title>
<sec id="S11">
<label>3.1</label>
<title>Homology modelling</title>
<p id="P15">In order to assesse the quality of modelled structure of TLR7 and TLR9, we access Structure Assesement tool under SWISS-MODEL server and found out both the structures are significant as more than 92% residues from both structures reside in Ramachandran plot favoured region signifying a stable stereochemical structure (<xref ref-type="supplementary-material" rid="SD1">Figure S1</xref>).</p>
</sec>
<sec id="S12">
<label>3.2</label>
<title>Motif analysis</title>
<p id="P16">Motif analysis played a crucial role in determining the immunoregulatory potency of the given RNA fragments in interacting with TLR proteins and also their role in inciting pro-inflammatory cytokine production.<sup>
<xref ref-type="bibr" rid="R33">33</xref>
</sup> According to outcomes from imRNA tool <xref ref-type="supplementary-material" rid="SD1">Figure S2A</xref> was modified where the number of motifs was plotted against the sequence length of the mRNAs to predict the interaction between mRNAs and TLRs. In support RPISeq tool developed predictions on RF and SVM classifier confirm the interactions as they scored above 0.5 and are visualized in <xref ref-type="supplementary-material" rid="SD1">Figure S2B-S2F</xref>.</p>
</sec>
<sec id="S13">
<label>3.3</label>
<title>Molecular docking studies and interactome analysis</title>
<p id="P17">Our study focuses principally on the interactions of the intracellular TLRs with the mRNA fragments, and molecular docking studies play a pivotal role in this study by precisely determining the most probable binding pocket. The docking algorithms used by the HDOCK program globally samples all the binding poses of the RNA to the protein using a fast and flexible Fourier transform (FFT) search strategy with focuses on cavity prediction and shape complementarity.<sup>
<xref ref-type="bibr" rid="R24">24</xref>
</sup> Further, all the sampled binding modes are analyzed by an iterative knowledge-based scoring function. The more negative the value, the higher the score. Overall, 40 RNA-protein docked complexes were generated in this study and the scores are furnished in <xref ref-type="supplementary-material" rid="SD1">Table S1</xref>. However, only the four topmost scoring docked complexes were selected for further experimentation and analysis.</p>
<sec id="S14">
<label>3.3.1</label>
<title>Interaction of NSP10 RNA fragment with TLR3</title>
<p id="P18">In accord to our docking studies, TLR3 binds with a much proficient binding pose with the RNA fragment encoding NSP10, with a high docking score of -404.77 which is higher than any other docking operation involving TLR3 like that of the RNA fragment of papain-like protease which binds with a score of -346.51 or that of the main protease which has a score of -333.76 (<xref ref-type="supplementary-material" rid="SD1">Table S1</xref>). While in search of insights of molecular docking PLIP study found the involvement of 251Arg, 252Asn, 277Thr residues in hydrogen bonding, 326Tyr, 359His in π-Cation interactions and Salt bridges from 32 and 319His (<xref ref-type="fig" rid="F2">Figure 2A</xref>, <xref ref-type="table" rid="T1">Table 1</xref>)</p>
</sec>
<sec id="S15">
<label>3.3.2</label>
<title>Interaction of Envelope-protein RNA fragment with TLR7</title>
<p id="P19">In this study, the docking operations determine a good binding pocket for E-protein mRNA within the TLR7 dimeric cavity, with a binding score of -381.60. PLIP analysis of the docking complex later reveals that the complex stability is regulated by hydrogen bonding interactions through residues <italic>viz.</italic> 684Lys, 707Ser, 708His, by π-Cation Interactions through 758(B)Lys, 781His, 782(B)His residues and through Salt Bridges with residues of 627Arg, 736Arg, 758(B)Lys, 820(B)His as shown in <xref ref-type="fig" rid="F2">Figure 2B</xref> and <xref ref-type="table" rid="T1">Table 1</xref>.</p>
</sec>
<sec id="S16">
<label>3.3.3</label>
<title>Interaction of NSP8 RNA fragment with TLR8 protein</title>
<p id="P20">Herein, the most probable binding pose of NSP8 RNA fragment and TLR8 is built with a definite score of -416.84, which is much higher than those poses comprising of the RNAs of PL-pro and Mpro which had scores of -360.49 and -355.80 respectively. PLIP analysis as in <xref ref-type="fig" rid="F3">Figure 3A</xref> again confirms these results as it shows that there exists a strong concerted interaction among the complex domains that are 426(B)Ser, 470(B)Phe, 473(B)Pro, 489(B)Ser, 513(B)Ser, etc residues in hydrogen bonding, 569Arg, 696(B)Arg, and 699Lys in π-Cation interactions and Salt bridges from 643(B)Arg, 673(B)Asp, 721His, etc. as shown in <xref ref-type="table" rid="T1">Table 1</xref>.</p>
</sec>
<sec id="S17">
<label>3.3.4</label>
<title>Interaction of S2 Subunit RNA fragment with TLR9 protein</title>
<p id="P21">Among the docked complexes with TLR9 possessing the S2 subunit mRNA fragment stood at the highest position with a score of -440.33. The molecular insights of this ligation are well supported by the PLIP analysis as finding involves 224Tyr, 247Arg, 248Val, 292Lys residues in hydrogen bonding, 311Arg in π-Cation interactions and Salt bridges from 207Lys, 287Glu, and 292Lys (<xref ref-type="fig" rid="F3">Figure 3B</xref>, <xref ref-type="table" rid="T1">Table 1</xref>).</p>
</sec>
</sec>
<sec id="S18">
<label>3.4</label>
<title>Simulation analysis</title>
<sec id="S19">
<label>3.4.1</label>
<title>Normal mode analysis (NMA)</title>
<p id="P22">iMODs server generates conformational morphing trajectories of the molecule as depicted in <xref ref-type="supplementary-material" rid="SD1">Figure S2G-S2J</xref> and enables us to inspect the compatibility and ultimate stability of the complex. Affine-model-based arrow within the structure represents the nature of domain dynamics (<xref ref-type="supplementary-material" rid="SD1">Figure S3A, S3B, S4A and S4B</xref>). While structure mobility and flexibility are categorized by deformability and B-factor plot (<xref ref-type="supplementary-material" rid="SD1">Figure S3C, S3D</xref> and <xref ref-type="supplementary-material" rid="SD1">Figure S4E, S4F</xref>). In deformability plot hinge regions defined the non-rigid helical contents and in B-factor distortions are atomic positional fluctuations. Calculations to measure eigenvalue are fully depended on the energy required to deform the structure, as <xref ref-type="supplementary-material" rid="SD1">Figure S4H</xref> with very low eigenvalue direct lower energy can deform the structure and infer greater stability. According to Abdelli et al. (2020),<sup>
<xref ref-type="bibr" rid="R34">34</xref>
</sup> variance shows a direct and inverse relation with eigenvalue as depicted in <xref ref-type="supplementary-material" rid="SD1">Figure S3I, S3J, S4I and S4J</xref>, where red colour represents individual and green to cumulative variance. In the covariance matrix, motions are categorized in different modes and visualized in <xref ref-type="supplementary-material" rid="SD1">Figure S3K and S3M</xref> with red, blue and white colour that signify variations among correlated, anti-correlated and uncorrelated motions respectively. In the end, the last outcome of NMA study, elastic network map graph is represented by <xref ref-type="supplementary-material" rid="SD1">Figure S4L and S4N</xref> where grey dots indicate the stiffness of the motions and springs direct the atomic connections of the complex.</p>
</sec>
<sec id="S20">
<label>3.4.2</label>
<title>Molecular dynamics (MD) simulation</title>
<p id="P23">Four most active complexes, those were primarily strained out according to their significant docking score were subjected to further analysis through MD simulation. MD is the computerized method of simulation that allows mobility of atoms and molecules for a given time to monitor the interaction and calculate the forces, that ultimately figure out the atomic level configuration of the complex structure and then visualize using several graphical plots.<sup>
<xref ref-type="bibr" rid="R35">35</xref>
</sup> Herein, RMSD plot in <xref ref-type="fig" rid="F4">Figure 4A</xref> reflects the structural stability of the backbone of different receptor TLRs of the four complexes and suggests complex TLR8-NSP8 is less stable among others. Where <xref ref-type="fig" rid="F4">Figure 4B and 4C</xref> define the compactness and solvent accessible area of that complexes as R<sub>g</sub> plot and SASA plot, respectively. At last the graphical plot of hydrogen bond clearly describes the insights of the complexes and supports the postulation reflected on RMSD, R<sub>g</sub> and SASA plots (<xref ref-type="fig" rid="F4">Figure 4D</xref>).</p>
</sec>
</sec>
<sec id="S21">
<label>3.5</label>
<title>mRNA induced conformational changes in TLRs during and after MD simulation</title>
<p id="P24">Apart from RMSD, Rg, SASA and hydrogen bond studies, we also analyse conformational changes of receptor TLRs arisen during simulation processes. Here, we prepared and visualized six different conformation on different time steps of each TLRs and revealed mRNA of NSP10, NSP8, S2 subunit of spike protein and Envelope protein have enough potential to change the conformation of extracellular domain of TLR3, TLR8, TLR9 and TLR7 respectively (<xref ref-type="fig" rid="F5">Figure 5</xref>).</p>
</sec>
</sec>
<sec id="S22" sec-type="discussion">
<label>4</label>
<title>Discussion</title>
<p id="P25">Toll-like receptors (TLRs) are the essential mediators and regulators of host immunity. The intracellular TLRs play a vital role in sensing the viral RNA and triggers the downstream activation of signalling cascade of immunomodulation. TLR3 dimerizes upon binding and recruits signal transfer proteins MyD88, TIRAP, TRAM, or TRIF in the cytoplasmic TIR domain.<sup>
<xref ref-type="bibr" rid="R36">36</xref>
</sup> Certain kinases alike IRAKs, TBK1, and IKKs are activated as well as TRAF6, as per different adaptors, thus leading to activation of the MAPK, NF-κB, or JNK-STAT pathways for promotion of the transcription of inflammatory cytokines and for production of IFN, IL-1β, IL-6, to coordinate the local or systemic inflammatory responses among which IL-1β and IL-6 are the major pro-inflammatory cytokines.<sup>
<xref ref-type="bibr" rid="R37">37</xref>
</sup> TLR8 protein has various similarities with TLR7 including their gene loci on the X chromosome and believed to possess a close phylogenetic relationship.<sup>
<xref ref-type="bibr" rid="R38">38</xref>
</sup> The binding to TLR7/8 to the RNA, recruits MyD88 which on one hand activates IRF-7 and on the other hand also activates IRAK-4 resulting in the activation of the transcription factor NF-κB and subsequent antiviral response.<sup>
<xref ref-type="bibr" rid="R39">39</xref>
</sup> Ligated TLR9 moves from the endoplasmic reticulum to the Golgi apparatus and lysosomes, recruting MyD88-dependent pathway, and resulting in IRF7-mediated IFN production or in proinflammatory responses by producing IL-6, IL-12, and TNFα through activation of the NF-κB.<sup>
<xref ref-type="bibr" rid="R40">40</xref>
</sup>
</p>
<p id="P26">This study focuses on the establishing the binding and potency of SARS-CoV-2 with the human intracellular TLRs including TLR 3, 7, 8, and 9. Regarding this crystal structures and templates are preliminarily obtained via X-Ray Diffraction techniques with resolution of most 2.50Å, considering good for molecular docking studies. Since the quality of results obtained from further experiments would rely on the stereochemical quality of modelling, and it showed the models had &gt;92% residues in favored regions of their respective Ramachandran plots (<xref ref-type="supplementary-material" rid="SD1">Figure S1</xref>) indicating standard quality of modelling.</p>
<p id="P27">The motif analysis recognizes the immunomodulated motifs within the RNA sequence that can stimulate the immune responses. According to imRNA tool the mRNA fragments are highly capable of interacting with the TLRs and influence immunomodulation (<xref ref-type="supplementary-material" rid="SD1">Figure S2A</xref>). Though mRNA of the S2 subunit and NSP8 proteins are almost similar in size and have the highest potency compared to others. While RPISeq tool strained out best candidates showing maximum potency in interaction for intracellular TLR 3, 7, 8 and 9. As RPISeq tool predicted a high interaction coefficient for NSP10 RNA with TLR3 as exhibited in <xref ref-type="supplementary-material" rid="SD1">Figure S2B</xref>. While the threshold SVM and RF classifier values for minimum interaction is 0.5 for SVM classifier as well as for RF classifier, in contrast, the NSP10 mRNA with SVM classifier value of 0.984 and RF classifier value of 0.8 it stands among the best candidates for interacting with TLR3. While prediction figure out E-protein RNA fragment is best in interact TLR7 with an RF classifier value of 0.75 and an SVM classifier value of 0.884 (<xref ref-type="supplementary-material" rid="SD1">Figure S2C</xref>). Later on, studies also revealed best interaction between NSP8 mRNA and TLR8 protein having SVM and RF classifier as high as 0.991 and 0.7 respectively (<xref ref-type="supplementary-material" rid="SD1">Figure S2D</xref>). Moreover, prediction again showed a higher probability of interaction of TLR9 with the S2 subunit with SVM classifier value of 0.868 and RF classifier value of 0.7 (<xref ref-type="supplementary-material" rid="SD1">Figure S2E</xref>).</p>
<p id="P28">Further, the molecular docking studies showed a similar trend by reflecting highest docking score to the complexes selected through RPISeq tool and in turn support the prediction of best docked structures (<xref ref-type="supplementary-material" rid="SD1">Table S1</xref>). After getting confirmation on best predicted structure through HDOCK we forwarded to next step of simulation to analyze the conformational stability and flexibility of that selected four structures viz. TLR8-NSP8 mRNA complex (<xref ref-type="fig" rid="F3">Figure 3A</xref>), TLR3- NSP10 mRNA complex as shown in <xref ref-type="fig" rid="F2">Figure 2A</xref>, TLR7-E mRNA complex in <xref ref-type="fig" rid="F2">Figure 2B</xref> and TLR9-S2 mRNA complex (<xref ref-type="fig" rid="F3">Figure 3B</xref>). Initially, the NMA study reveals all the compounds have better stability as it reflects quite similar and significant eigenvalue scores, those are 3.154899x10<sup>-5</sup> for TLR8-NSP8 mRNA complex as shown in <xref ref-type="supplementary-material" rid="SD1">Figure S4G</xref>, 1.27056x10<sup>-5</sup> TLR3-NSP10 mRNA complex (<xref ref-type="supplementary-material" rid="SD1">Figure S3G</xref>), 7.042567x10<sup>-5</sup> TLR7-E mRNA complex as in <xref ref-type="supplementary-material" rid="SD1">Figure S3H</xref>, and 9.131746 x10<sup>-5</sup> TLR9-S2 mRNA complex (<xref ref-type="supplementary-material" rid="SD1">Figure S4H</xref>). Later, MD simulation studies figure out postulation of NMA studies is not fully accepted as TLR8-NSP8 mRNA complex found as unstable throughout the simulation process in the RMSD plot <xref ref-type="fig" rid="F4">Figure 4A</xref>. The PLIP analysis <xref ref-type="table" rid="T1">Table 1</xref> and hydrogen bond plot <xref ref-type="fig" rid="F4">Figure 4D</xref> finally reveals the interactions between the mRNA ligand and the TLR proteins and the reasons for the stability of the complexes. At the end, our final experiment on changes of conformation of TLRs after binding and simulation hypothesized as mRNA of NSP10, S2 and E proteins are potent enough to bind with TLR3, TLR9 and TLR7 and trigger downstream cascade reactions (<xref ref-type="fig" rid="F5">Figure 5</xref>).</p>
</sec>
<sec id="S23" sec-type="conclusions">
<label>5</label>
<title>Conclusion</title>
<p id="P29">The intracellular TLRs play a vital role in the recognition of PAMPs and viral pathogens and it is of utmost necessity to understand the sensing of SARS-CoV-2 viral RNA with the human intracellular TLRs including TLR3,7,8 and 9. The current study primarily focuses on the comparative binding of mRNAs of SARS-CoV-2 with the human intracellular TLRs. Later, NMA study found out stability between complexes with significant values for TLR8-NSP8 mRNA complex, TLR3-NSP10 mRNA complex, TLR7-E mRNA complex, and TLR9-S2 mRNA complex. While, upon MD simulation it is confined that the mRNA of NSP8 has lower potency to make complex with TLR8. In turn significant binding potency of NSP10, S2, and E proteins mRNA with TLR3, TLR9, and TLR7 respectively, help us to conclude our study and we infer complexes of TLR3-NSP10 mRNA, TLR7-E mRNA, and TLR9-S2 mRNA can potentially trigger the downstream activation and proliferation of immune responses and can be used in validation for therapeutic action.</p>
</sec>
<sec sec-type="supplementary-material" id="SM">
<title>Supplementary Material</title>
<supplementary-material content-type="local-data" id="SD1">
<label>Supplementary material</label>
<media xlink:href="EMS104093-supplement-Supplementary_material.pdf" mimetype="application" mime-subtype="pdf" id="N66470" position="anchor"/>
</supplementary-material>
</sec>
</body>
<back>
<ack id="S24">
<title>Acknowledgment</title>
<p>We do acknowledge the efforts of all the doctors, health workers, social workers, scientists, and researchers currently working endlessly against coronavirus disease worldwide. We have kept selected studies as reference due to the limitation in space, but we appreciate all the uncited articles dedicated to the research on coronavirus. RP thanks the Department of Higher Education, Govt. of West Bengal for his Merit-cum-means Scholarship.</p>
</ack>
<fn-group>
<fn id="FN2" fn-type="conflict">
<p id="P30">
<bold>Conflict of Interest</bold>
</p>
<p id="P31">The authors declare that there is no conflict of interest.</p>
</fn>
<fn id="FN3" fn-type="con">
<p id="P32">
<bold>Authors’ Contributions</bold>
</p>
<p id="P33">AC, NCD performed all experiments; AC, NCD, and RP write the manuscript; SM design the experiments, analyses the result, edited the manuscript and supervise the study.</p>
</fn>
</fn-group>
<ref-list>
<ref id="R1">
<label>[1]</label>
<element-citation publication-type="web">
<collab>World Health Organization</collab>
<article-title>COVID-19 Pandemic update</article-title>
<date-in-citation>Accessed 7th November</date-in-citation>
<comment>Situation report website. <ext-link ext-link-type="uri" xlink:href="https://covid19.who.int">https://covid19.who.int</ext-link>
</comment>
</element-citation>
</ref>
<ref id="R2">
<label>[2]</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hui</surname>
<given-names>DSI</given-names>
</name>
<name>
<surname>Azhar</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Madani</surname>
<given-names>TA</given-names>
</name>
<etal/>
</person-group>
<article-title>The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health-—The latest 2019 novel coronavirus outbreak in Wuhan, China</article-title>
<source>Int J Infect Dis</source>
<year>2020</year>
<volume>91</volume>
<fpage>264</fpage>
<lpage>266</lpage>
<pub-id pub-id-type="doi">10.1016/j.ijid.2020.01.009</pub-id>
</element-citation>
</ref>
<ref id="R3">
<label>[3]</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dhand</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>Coughs and Sneezes: Their Role in Transmission of Respiratory Viral Infections, Including SARS-CoV-2</article-title>
<source>Am J Respir Crit Care Med</source>
<year>2020</year>
<volume>202</volume>
<issue>5</issue>
<fpage>651</fpage>
<lpage>659</lpage>
<pub-id pub-id-type="doi">10.1164/rccm.202004-1263PP</pub-id>
</element-citation>
</ref>
<ref id="R4">
<label>[4]</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Amirian</surname>
<given-names>ES</given-names>
</name>
</person-group>
<article-title>Potential fecal transmission of SARS-CoV-2: Current evidence and implications for public health</article-title>
<source>International Journal of Infectious Diseases</source>
<year>2020</year>
<volume>95</volume>
<fpage>363</fpage>
<lpage>370</lpage>
<pub-id pub-id-type="doi">10.1016/j.ijid.2020.04.057</pub-id>
</element-citation>
</ref>
<ref id="R5">
<label>[5]</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Otter</surname>
<given-names>JA</given-names>
</name>
<name>
<surname>Donskey</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Yezli</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Douthwaite</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Goldenberg</surname>
<given-names>SD</given-names>
</name>
<name>
<surname>Weber</surname>
<given-names>DJ</given-names>
</name>
</person-group>
<article-title>Transmission of SARS and MERS coronaviruses and influenza virus in healthcare settings: the possible role of dry surface contamination</article-title>
<source>Journal of Hospital Infection</source>
<year>2016</year>
<volume>92</volume>
<issue>3</issue>
<fpage>235</fpage>
<lpage>250</lpage>
<pub-id pub-id-type="doi">10.1016/j.jhin.2015.08.027</pub-id>
</element-citation>
</ref>
<ref id="R6">
<label>[6]</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Naqvi</surname>
<given-names>AAT</given-names>
</name>
<name>
<surname>Fatima</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Mohammad</surname>
<given-names>T</given-names>
</name>
<etal/>
</person-group>
<article-title>Insights into SARS-CoV-2 genome, structure, evolution, pathogenesis and therapies: Structural genomics approach</article-title>
<source>Biochim Biophys Acta Mol Basis Dis</source>
<year>2020</year>
<volume>1866</volume>
<issue>10</issue>
<fpage>165878</fpage>
<pub-id pub-id-type="doi">10.1016/j.bbadis.2020.165878</pub-id>
</element-citation>
</ref>
<ref id="R7">
<label>[7]</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wu</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>ZJ</given-names>
</name>
</person-group>
<article-title>Innate Immune Sensing and Signaling of Cytosolic Nucleic Acids</article-title>
<source>Annu Rev Immunol</source>
<year>2014</year>
<volume>32</volume>
<issue>1</issue>
<fpage>461</fpage>
<lpage>488</lpage>
<pub-id pub-id-type="doi">10.1146/annurev-immunol-032713-120156</pub-id>
</element-citation>
</ref>
<ref id="R8">
<label>[8]</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Guo</surname>
<given-names>Y-R</given-names>
</name>
<name>
<surname>Cao</surname>
<given-names>Q-D</given-names>
</name>
<name>
<surname>Hong</surname>
<given-names>Z-S</given-names>
</name>
<etal/>
</person-group>
<article-title>The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak – an update on the status</article-title>
<source>Military Medical Research</source>
<year>2020</year>
<volume>7</volume>
<issue>1</issue>
<fpage>11</fpage>
<pub-id pub-id-type="doi">10.1186/s40779-020-00240-0</pub-id>
</element-citation>
</ref>
<ref id="R9">
<label>[9]</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Onofrio</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Caraglia</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Facchini</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Margherita</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Placido</surname>
<given-names>SD</given-names>
</name>
<name>
<surname>Buonerba</surname>
<given-names>C</given-names>
</name>
</person-group>
<article-title>Toll-like receptors and COVID-19: a two-faced story with an exciting ending</article-title>
<source>Future Sci OA</source>
<year>2020</year>
<volume>6</volume>
<issue>8</issue>
<fpage>FSO605</fpage>
<lpage>FSO605</lpage>
<pub-id pub-id-type="doi">10.2144/fsoa-2020-0091</pub-id>
</element-citation>
</ref>
<ref id="R10">
<label>[10]</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cao</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>T</given-names>
</name>
</person-group>
<article-title>COVID-19: towards understanding of pathogenesis</article-title>
<source>Cell Res</source>
<year>2020</year>
<volume>30</volume>
<issue>5</issue>
<fpage>367</fpage>
<lpage>369</lpage>
<pub-id pub-id-type="doi">10.1038/s41422-020-0327-4</pub-id>
</element-citation>
</ref>
<ref id="R11">
<label>[11]</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Patra</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Das</surname>
<given-names>NC</given-names>
</name>
<name>
<surname>Mukherjee</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>Targeting human TLRs to combat COVID-19: A solution?</article-title>
<source>J Med Virol</source>
<year>2020</year>
<pub-id pub-id-type="doi">10.1002/jmv.26387</pub-id>
</element-citation>
</ref>
<ref id="R12">
<label>[12]</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Choudhury</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Mukherjee</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>In silico studies on the comparative characterization of the interactions of SARS-CoV-2 spike glycoprotein with ACE-2 receptor homologs and human TLRs</article-title>
<source>J Med Virol</source>
<year>2020</year>
<volume>92</volume>
<fpage>2105</fpage>
<lpage>2113</lpage>
<pub-id pub-id-type="doi">10.1002/jmv.25987</pub-id>
</element-citation>
</ref>
<ref id="R13">
<label>[13]</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bhattacharya</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Sharma</surname>
<given-names>AR</given-names>
</name>
<name>
<surname>Patra</surname>
<given-names>P</given-names>
</name>
<etal/>
</person-group>
<article-title>Development of epitope-based peptide vaccine against novel coronavirus 2019 (SARS-COV-2): Immunoinformatics approach</article-title>
<source>J Med Virol</source>
<year>2020</year>
<volume>92</volume>
<issue>6</issue>
<fpage>618</fpage>
<lpage>631</lpage>
<pub-id pub-id-type="doi">10.1002/jmv.25736</pub-id>
</element-citation>
</ref>
<ref id="R14">
<label>[14]</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Petes</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Odoardi</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Gee</surname>
<given-names>K</given-names>
</name>
</person-group>
<article-title>The Toll for Trafficking: Toll-Like Receptor 7 Delivery to the Endosome</article-title>
<source>Frontiers in Immunology</source>
<year>2017</year>
<volume>8</volume>
<fpage>1075</fpage>
<pub-id pub-id-type="doi">10.3389/fimmu.2017.01075</pub-id>
</element-citation>
</ref>
<ref id="R15">
<label>[15]</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Ohto</surname>
<given-names>U</given-names>
</name>
<name>
<surname>Shibata</surname>
<given-names>T</given-names>
</name>
<etal/>
</person-group>
<article-title>Structural Analysis Reveals that Toll-like Receptor 7 Is a Dual Receptor for Guanosine and Single-Stranded RNA</article-title>
<source>Immunity</source>
<year>2016</year>
<volume>45</volume>
<issue>4</issue>
<fpage>737</fpage>
<lpage>748</lpage>
<pub-id pub-id-type="doi">10.1016/j.immuni.2016.09.011</pub-id>
</element-citation>
</ref>
<ref id="R16">
<label>[16]</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hemmi</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Kaisho</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Takeuchi</surname>
<given-names>O</given-names>
</name>
<etal/>
</person-group>
<article-title>Small anti-viral compounds activate immune cells via the TLR7 MyD88–dependent signaling pathway</article-title>
<source>Nature Immunology</source>
<year>2002</year>
<volume>3</volume>
<issue>2</issue>
<fpage>196</fpage>
<lpage>200</lpage>
<pub-id pub-id-type="doi">10.1038/ni758</pub-id>
</element-citation>
</ref>
<ref id="R17">
<label>[17]</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mukherjee</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Karmakar</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Babu</surname>
<given-names>SPS</given-names>
</name>
</person-group>
<article-title>TLR2 and TLR4 mediated host immune responses in major infectious diseases: a review</article-title>
<source>The Brazilian Journal of Infectious Diseases</source>
<year>2016</year>
<volume>20</volume>
<issue>2</issue>
<fpage>193</fpage>
<lpage>204</lpage>
<pub-id pub-id-type="doi">10.1016/j.bjid.2015.10.011</pub-id>
</element-citation>
</ref>
<ref id="R18">
<label>[18]</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pérez Cañadillas</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>Varani</surname>
<given-names>G</given-names>
</name>
</person-group>
<article-title>Recognition of GU-rich polyadenylation regulatory elements by human CstF-64 protein</article-title>
<source>EMBO J</source>
<year>2003</year>
<volume>22</volume>
<issue>11</issue>
<fpage>2821</fpage>
<lpage>2830</lpage>
<pub-id pub-id-type="doi">10.1093/emboj/cdg259</pub-id>
</element-citation>
</ref>
<ref id="R19">
<label>[19]</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Fan</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Lai</surname>
<given-names>Y</given-names>
</name>
<etal/>
</person-group>
<article-title>Coronavirus infections and immune responses</article-title>
<source>Journal of Medical Virology</source>
<year>2020</year>
<volume>92</volume>
<issue>4</issue>
<fpage>424</fpage>
<lpage>432</lpage>
<pub-id pub-id-type="doi">10.1002/jmv.25685</pub-id>
</element-citation>
</ref>
<ref id="R20">
<label>[20]</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yoshimoto</surname>
<given-names>FK</given-names>
</name>
</person-group>
<article-title>The Proteins of Severe Acute Respiratory Syndrome Coronavirus-2 (SARS CoV-2 or n-COV19), the Cause of COVID-19</article-title>
<source>The Protein Journal</source>
<year>2020</year>
<volume>39</volume>
<issue>3</issue>
<fpage>198</fpage>
<lpage>216</lpage>
<pub-id pub-id-type="doi">10.1007/s10930-020-09901-4</pub-id>
</element-citation>
</ref>
<ref id="R21">
<label>[21]</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vens</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Rosso</surname>
<given-names>M-N</given-names>
</name>
<name>
<surname>Danchin</surname>
<given-names>EGJ</given-names>
</name>
</person-group>
<article-title>Identifying discriminative classification-based motifs in biological sequences</article-title>
<source>Bioinformatics</source>
<year>2011</year>
<volume>27</volume>
<issue>9</issue>
<fpage>1231</fpage>
<lpage>1238</lpage>
<pub-id pub-id-type="doi">10.1093/bioinformatics/btr110</pub-id>
</element-citation>
</ref>
<ref id="R22">
<label>[22]</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yi</surname>
<given-names>H-C</given-names>
</name>
<name>
<surname>You</surname>
<given-names>Z-H</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>D-S</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Jiang</surname>
<given-names>T-H</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>L-P</given-names>
</name>
</person-group>
<article-title>A Deep Learning Framework for Robust and Accurate Prediction of ncRNA-Protein Interactions Using Evolutionary Information</article-title>
<source>Molecular Therapy - Nucleic Acids</source>
<year>2018</year>
<volume>11</volume>
<fpage>337</fpage>
<lpage>344</lpage>
<pub-id pub-id-type="doi">10.1016/j.omtn.2018.03.001</pub-id>
</element-citation>
</ref>
<ref id="R23">
<label>[23]</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Muppirala</surname>
<given-names>UK</given-names>
</name>
<name>
<surname>Honavar</surname>
<given-names>VG</given-names>
</name>
<name>
<surname>Dobbs</surname>
<given-names>D</given-names>
</name>
</person-group>
<article-title>Predicting RNA-Protein Interactions Using Only Sequence Information</article-title>
<source>BMC Bioinformatics</source>
<year>2011</year>
<volume>12</volume>
<issue>1</issue>
<fpage>489</fpage>
<pub-id pub-id-type="doi">10.1186/1471-2105-12-489</pub-id>
</element-citation>
</ref>
<ref id="R24">
<label>[24]</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yan</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>S-Y</given-names>
</name>
</person-group>
<article-title>HDOCK: a web server for protein–protein and protein–DNA/RNA docking based on a hybrid strategy</article-title>
<source>Nucleic Acids Research</source>
<year>2017</year>
<volume>45</volume>
<issue>W1</issue>
<fpage>W365</fpage>
<lpage>W373</lpage>
<pub-id pub-id-type="doi">10.1093/nar/gkx407\</pub-id>
</element-citation>
</ref>
<ref id="R25">
<label>[25]</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Salentin</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Schreiber</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Haupt</surname>
<given-names>VJ</given-names>
</name>
<name>
<surname>Adasme</surname>
<given-names>MF</given-names>
</name>
<name>
<surname>Schroeder</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>PLIP: fully automated protein-ligand interaction profiler</article-title>
<source>Nucleic Acids Res</source>
<year>2015</year>
<volume>43</volume>
<issue>W1</issue>
<fpage>W443</fpage>
<lpage>W447</lpage>
<pub-id pub-id-type="doi">10.1093/nar/gkv315</pub-id>
</element-citation>
</ref>
<ref id="R26">
<label>[26]</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>López-Blanco</surname>
<given-names>JR</given-names>
</name>
<name>
<surname>Aliaga</surname>
<given-names>JI</given-names>
</name>
<name>
<surname>Quintana-Ortí</surname>
<given-names>ES</given-names>
</name>
<name>
<surname>Chacón</surname>
<given-names>P</given-names>
</name>
</person-group>
<article-title>iMODS: internal coordinates normal mode analysis server</article-title>
<source>Nucleic Acids Research</source>
<year>2014</year>
<volume>42</volume>
<issue>W1</issue>
<fpage>W271</fpage>
<lpage>W276</lpage>
<pub-id pub-id-type="doi">10.1093/nar/gku339</pub-id>
</element-citation>
</ref>
<ref id="R27">
<label>[27]</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Das</surname>
<given-names>NC</given-names>
</name>
<name>
<surname>Patra</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Gupta</surname>
<given-names>PSSen</given-names>
</name>
<etal/>
</person-group>
<article-title>Designing of a novel multi-epitope peptide based vaccine against Brugia malayi: An in silico approach</article-title>
<source>Infect Genet Evol</source>
<year>2020</year>
<fpage>104633</fpage>
<comment>Published online</comment>
<pub-id pub-id-type="doi">10.1016/j.meegid.2020.104633</pub-id>
</element-citation>
</ref>
<ref id="R28">
<label>[28]</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cheatham</surname>
<given-names>TE</given-names>
</name>
<name>
<surname>Brooks</surname>
<given-names>BR</given-names>
</name>
<name>
<surname>Kollman</surname>
<given-names>PA</given-names>
</name>
</person-group>
<article-title>Molecular Modeling of Nucleic Acid Structure: Setup and Analysis</article-title>
<source>Curr Protoc Nucleic Acid Chem</source>
<year>2001</year>
<volume>6</volume>
<fpage>7.10.1</fpage>
<lpage>7.10.17</lpage>
<pub-id pub-id-type="doi">10.1002/0471142700.nc0710s06</pub-id>
</element-citation>
</ref>
<ref id="R29">
<label>[29]</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jo</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Iyer</surname>
<given-names>VG</given-names>
</name>
<name>
<surname>Im</surname>
<given-names>W</given-names>
</name>
</person-group>
<article-title>CHARMM-GUI: a web-based graphical user interface for CHARMM</article-title>
<source>J Comput Chem</source>
<year>2008</year>
<volume>29</volume>
<issue>11</issue>
<fpage>1859</fpage>
<lpage>1865</lpage>
<pub-id pub-id-type="doi">10.1002/jcc.20945</pub-id>
</element-citation>
</ref>
<ref id="R30">
<label>[30]</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lee</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Cheng</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Swails</surname>
<given-names>JM</given-names>
</name>
<etal/>
</person-group>
<article-title>CHARMM-GUI Input Generator for NAMD, GROMACS, AMBER, OpenMM, and CHARMM/OpenMM Simulations Using the CHARMM36 Additive Force Field</article-title>
<source>J Chem Theory Comput</source>
<year>2016</year>
<volume>12</volume>
<issue>1</issue>
<fpage>405</fpage>
<lpage>413</lpage>
<pub-id pub-id-type="doi">10.1021/acs.jctc.5b00935</pub-id>
</element-citation>
</ref>
<ref id="R31">
<label>[31]</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lee</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Hitzenberger</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Rieger</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Kern</surname>
<given-names>NR</given-names>
</name>
<name>
<surname>Zacharias</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Im</surname>
<given-names>W</given-names>
</name>
</person-group>
<article-title>CHARMM-GUI supports the Amber force fields</article-title>
<source>J Chem Phys</source>
<year>2020</year>
<volume>153</volume>
<issue>3</issue>
<comment>035103</comment>
<pub-id pub-id-type="doi">10.1063/5.0012280</pub-id>
</element-citation>
</ref>
<ref id="R32">
<label>[32]</label>
<element-citation publication-type="book">
<person-group person-group-type="author">
<name>
<surname>Ha</surname>
<given-names>J-H</given-names>
</name>
<name>
<surname>Loh</surname>
<given-names>SN</given-names>
</name>
</person-group>
<article-title>Protein conformational switches: from nature to design</article-title>
<source>Chemistry</source>
<publisher-loc>Weinheim an der Bergstrasse, Germany</publisher-loc>
<year>2012</year>
<volume>18</volume>
<issue>26</issue>
<fpage>7984</fpage>
<lpage>7999</lpage>
<pub-id pub-id-type="doi">10.1002/chem.201200348</pub-id>
</element-citation>
</ref>
<ref id="R33">
<label>[33]</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nagpal</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Chaudhary</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Dhanda</surname>
<given-names>SK</given-names>
</name>
<name>
<surname>Raghava</surname>
<given-names>GPS</given-names>
</name>
</person-group>
<article-title>Computational Prediction of the Immunomodulatory Potential of RNA Sequences</article-title>
<source>Methods Mol Biol</source>
<year>2017</year>
<volume>1632</volume>
<fpage>75</fpage>
<lpage>90</lpage>
<pub-id pub-id-type="doi">10.1007/978-1-4939-7138-1_5</pub-id>
</element-citation>
</ref>
<ref id="R34">
<label>[34]</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Abdelli</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Hassani</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Bekkel Brikci</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Ghalem</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>In silico study the inhibition of angiotensin converting enzyme 2 receptor of COVID-19 by Ammoides verticillata components harvested from Western Algeria</article-title>
<source>J Biomol Struct Dyn</source>
<year>2020</year>
<fpage>1</fpage>
<lpage>14</lpage>
<pub-id pub-id-type="doi">10.1080/07391102.2020.1763199</pub-id>
</element-citation>
</ref>
<ref id="R35">
<label>[35]</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hollingsworth</surname>
<given-names>SA</given-names>
</name>
<name>
<surname>Dror</surname>
<given-names>RO</given-names>
</name>
</person-group>
<article-title>Molecular Dynamics Simulation for All</article-title>
<source>Neuron</source>
<year>2018</year>
<volume>99</volume>
<issue>6</issue>
<fpage>1129</fpage>
<lpage>1143</lpage>
<pub-id pub-id-type="doi">10.1016/j.neuron.2018.08.011</pub-id>
</element-citation>
</ref>
<ref id="R36">
<label>[36]</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sen</surname>
<given-names>GC</given-names>
</name>
<name>
<surname>Sarkar</surname>
<given-names>SN</given-names>
</name>
</person-group>
<article-title>Transcriptional signaling by double-stranded RNA: role of TLR3</article-title>
<source>Cytokine &amp; Growth Factor Reviews</source>
<year>2005</year>
<volume>16</volume>
<issue>1</issue>
<fpage>1</fpage>
<lpage>14</lpage>
<pub-id pub-id-type="doi">10.1016/j.cytogfr.2005.01.006</pub-id>
</element-citation>
</ref>
<ref id="R37">
<label>[37]</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mukherjee</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Huda</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Sinha Babu</surname>
<given-names>SP</given-names>
</name>
</person-group>
<article-title>Toll-like receptor polymorphism in host immune response to infectious diseases: A review</article-title>
<source>Scandinavian Journal of Immunology</source>
<year>2019</year>
<volume>90</volume>
<issue>1</issue>
<fpage>e12771</fpage>
<pub-id pub-id-type="doi">10.1111/sji.12771</pub-id>
</element-citation>
</ref>
<ref id="R38">
<label>[38]</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Philbin</surname>
<given-names>VJ</given-names>
</name>
<name>
<surname>Iqbal</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Boyd</surname>
<given-names>Y</given-names>
</name>
<etal/>
</person-group>
<article-title>Identification and characterization of a functional, alternatively spliced Toll-like receptor 7 (TLR7) and genomic disruption of TLR8 in chickens</article-title>
<source>Immunology</source>
<year>2005</year>
<volume>114</volume>
<issue>4</issue>
<fpage>507</fpage>
<lpage>521</lpage>
<pub-id pub-id-type="doi">10.1111/j.1365-2567.2005.02125.x</pub-id>
</element-citation>
</ref>
<ref id="R39">
<label>[39]</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gringhuis</surname>
<given-names>SI</given-names>
</name>
<name>
<surname>van der Vlist</surname>
<given-names>M</given-names>
</name>
<name>
<surname>van den Berg</surname>
<given-names>LM</given-names>
</name>
<name>
<surname>den Dunnen</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Litjens</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Geijtenbeek</surname>
<given-names>TBH</given-names>
</name>
</person-group>
<article-title>HIV-1 exploits innate signaling by TLR8 and DC-SIGN for productive infection of dendritic cells</article-title>
<source>Nature Immunology</source>
<year>2010</year>
<volume>11</volume>
<issue>5</issue>
<fpage>419</fpage>
<lpage>426</lpage>
<pub-id pub-id-type="doi">10.1038/ni.1858</pub-id>
</element-citation>
</ref>
<ref id="R40">
<label>[40]</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hemmi</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Akira</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>TLR Signalling and the Function of Dendritic Cells</article-title>
<source>Chemical Immunology and Allergy</source>
<year>2005</year>
<volume>86</volume>
<fpage>120</fpage>
<lpage>135</lpage>
<pub-id pub-id-type="doi">10.1159/000086657</pub-id>
</element-citation>
</ref>
</ref-list>
</back>
<floats-group>
<fig id="F1" position="float">
<label>Figure 1</label>
<caption>
<p>A. Conceptual representation of the SARS-CoV-2 genome. B. TLR3 C. TLR7 D. TLR8 E. TLR9.</p>
</caption>
<graphic xlink:href="EMS104093-f001"/>
</fig>
<fig id="F2" position="float">
<label>Figure 2</label>
<caption>
<p>A. Molecular interaction between NSP10 RNA fragment and TLR3 protein. (i) Zoomed in configuration (ii) Detailed bonding interactions determined by PLIP. Solid blue lines represent Hydrogen bonds, dotted orange lines represent π-Cation interactions, while dotted yellow lines denote Salt bridges. B. Molecular interaction between E-protein RNA fragment and TLR7 protein. (i) Zoomed in configuration (ii) Detailed bonding interactions determined by PLIP. Solid blue lines represent Hydrogen bonds, dotted orange lines represent π-Cation interactions, while dotted yellow lines denote Salt bridges. It is to be noted that for the sake of perceptual clarity some residues have been intentionally omitted from the diagram, however the same have been furnished in <xref ref-type="table" rid="T1">table 1</xref>.</p>
</caption>
<graphic xlink:href="EMS104093-f002"/>
</fig>
<fig id="F3" position="float">
<label>Figure 3</label>
<caption>
<p>A. Molecular interaction between NSP8 RNA fragment and TLR8 protein. (i) Zoomed in configuration (ii) Detailed bonding interactions determined by PLIP. Solid blue lines represent Hydrogen bonds, dotted orange lines represent π-Cation interactions, while dotted yellow lines denote Salt bridges. B. Molecular interaction between S2-subunit RNA fragment and TLR9 protein. (i) Zoomed in configuration (ii) Detailed bonding interactions determined by PLIP. Solid blue lines represent Hydrogen bonds, dotted orange lines represent π-Cation interactions, while dotted yellow lines denote Salt bridges. It is to be noted that for the sake of perceptual clarity some residues have been intentionally omitted from the diagram, however the same have been furnished in <xref ref-type="table" rid="T1">table 1</xref>.</p>
</caption>
<graphic xlink:href="EMS104093-f003"/>
</fig>
<fig id="F4" position="float">
<label>Figure 4</label>
<caption>
<p>
<bold>Molecular dynamic (MD) simulation study</bold>. Reflecting outcomes generated during MD simulation studies of TLR3-NSP10 mRNA complex, TLR7-E protein mRNA complex, TLR8-NSP8 mRNA complex and TLR9-S2 protein mRNA complex. A. RMSD plots. B. Rg (Radius of gyration) plots. C. SASA plots. D. Graphical presentation of Hydrogen bonds. (TLR3-NSP10 mRNA complex shown in red, TLR8-NSP8 mRNA complex shown in violet, TLR9-S2 protein mRNA complex shown in black and TLR7-E protein mRNA complex in green).</p>
</caption>
<graphic xlink:href="EMS104093-f004"/>
</fig>
<fig id="F5" position="float">
<label>Figure 5</label>
<caption>
<p>
<bold>mRNA induced conformational changes in TLR3, TLR7, TLR8 and TLR9.</bold> Representing changes in helix, sheet, and loop in the structure of TLRs at various time points of molecular dynamic simulation. A represents changes in TLR3 after NSP10 mRNA induction. B signifies envelope (E) protein mRNA induced alteration of TLR7. C represents changes in TLR9 after S2 subunit of spike protein mRNA induction. While D exhibits NSP8 mRNA induced alteration of TLR8. Red is depicting the helix, yellows are the sheets, and loops are given as green.</p>
</caption>
<graphic xlink:href="EMS104093-f005"/>
</fig>
<table-wrap id="T1" position="float" orientation="portrait">
<label>Table 1</label>
<caption>
<title>Residues involved in bonding interactions among the given docked complexes.</title>
</caption>
<table frame="box" rules="all">
<thead>
<tr>
<th align="left" valign="top" rowspan="2">Complex</th>
<th align="left" valign="top" colspan="3">Interacting residues</th>
</tr>
<tr>
<th align="left" valign="top">Hydrogen bonding residues</th>
<th align="left" valign="top">π-Cation Interactions</th>
<th align="left" valign="top">Salt Bridges</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" valign="top">TLR3 with NSP10 RNA</td>
<td align="left" valign="top">251ARG, 252ASN, 277THR, 322PHE</td>
<td align="left" valign="top">326TYR, 359HIS</td>
<td align="left" valign="top">32HIS, 319HIS</td>
</tr>
<tr>
<td align="left" valign="top">TLR7 with E protein RNA</td>
<td align="left" valign="top">684LYS, 707SER, 708HIS, 710(B)GLN, 731LYS, 732ASN, 734(B)GLN, 736ARG, 755SER, 756SER, 758LYS, 782HIS, 784(B)ARG</td>
<td align="left" valign="top">758(B)LYS, 781HIS, 782(B)HIS</td>
<td align="left" valign="top">627ARG, 736ARG, 758(B)LYS, 820(B)HIS</td>
</tr>
<tr>
<td align="left" valign="top">TLR8 with NSP8 RNA</td>
<td align="left" valign="top">426(B)SER, 470(B)PHE, 473(B)PRO, 489(B)SER, 513(B)SER, 538(B)THR, 562(B)SER, 563TYR, 569ARG, 590(B)ASN, 592(B)SER, 672(B)ASN, 696(B)ARG, 699LYS, 723ARG, 779ASP, 797(B)ARG, 810ARG</td>
<td align="left" valign="top">569ARG, 696(B)ARG, 699LYS</td>
<td align="left" valign="top">375(B)ARG, 643(B)ARG, 673(B)ASP, 721HIS, 723(B)ARG, 749(B)LYS</td>
</tr>
<tr>
<td align="left" valign="top">TLR9 with S2 subunit RNA</td>
<td align="left" valign="top">224TYR, 247ARG, 248VAL, 292LYS, 311ARG, 312VAL, 335GLN, 337ARG, 340ASN, 397ARG, 399GLN, 464GLU</td>
<td align="left" valign="top">311ARG</td>
<td align="left" valign="top">207LYS, 287GLU, 292LYS, 337ARG, 368GLU, 467ARG</td>
</tr>
</tbody>
</table>
</table-wrap>
</floats-group>
</article>
